Reason for request
Re-assessment of the actual benefit at the request of the Transparency
Clinical Benefit
| Low |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
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
87nHzTwQthDhW1Fg
Listen
